Johnson & Johnson (JNJ) Subsidiary Gets Class I Recall for Implantable Infusion Pumps
7/26/2013 8:48:05 AM
Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!
Codman & Shurtleff, a division of Johnson & Johnson subsidiary DePuy Synthes, gets the FDA's highest warning level for issues with certain lots of its programmable infusion pumps. The FDA puts its highest-risk label on a recall of programmable infusion pumps made by Codman &Shurtleff Inc., a division of Johnson & Johnson (NYSE:JNJ) subsidiary DePuy Orthopaedics. Codman's implanted MedStream pumps were recalled over a potential defect in a component that measures the contents of the pump reservoir.
Help employers find you! Check out all the jobs and post your resume.
comments powered by